Dermatol. praxi. 2013;7(4):175-179

Bacterial and yeast lysates and the use in the clinical practice

doc.MUDr.Jaromír Bystroň, CSc.
Oddělení alergologie a klinické imunologie Fakultní nemocnice Olomouc

The author presents an overview of the mechanisms of action of bacterial immunomodulators and discusses the indications and the

most common issues concerning the use of bacterial lysates in clinical practice.

Keywords: bacterial lysates, immunomodulation

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bystroň J. Bacterial and yeast lysates and the use in the clinical practice. Dermatol. praxi. 2013;7(4):175-179.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Viktorinová, Koukalová, Bystroň. Kožní testy u pacientek léčených vakcínou KANVAKOL, Klin. Mikrobiol. Inf. Lék. 1999; 5: 18-22.
    2. Nimier K, Wolff F, Allouch PY, et al. Protective effects of RU 41740, a bacterial immunomodulator, against experimental infection: induction of cytokine and immunoglobulin release in mice after oral administration. Int J Immunopharmacol 1999; 21(9): 561-574. Go to original source... Go to PubMed...
    3. Saada HN, Azab KS, Zahran AM. Post-radiation effect of Broncho-vaxom, OM-85 BV, and its relationship to anti-oxidant activities. Pharmazie 2001; 56(8): 654-656. Go to PubMed...
    4. Guggenbichler JP. konference: Slizniční imunita a uplatnění imunomodulace v alergologii, pediatrii, geriatrii a urologii. Praha, Brno, Bratislava květen 2006 (sborník).
    5. Ferenčík M. Receptory podobné Toll (TLRs), prirodzená imunita a alergický zápal. Alergie 2003; 1: 35-42.
    6. Kalliomaki M, Salminen S, Arvilommi, et al. Probiotics in primary prevention of atopic disease: a randomized placebo.controlled trial. Lancet 2001; 375: 1076-1079. Go to original source... Go to PubMed...
    7. Lodinová-Žádníková R. Probiotika v pediatrii: Snížení rizika nosokomiálních infekcí perorálním osídlením probiotickým kmenem E.coli po narození a jeho vliv na frekvenci opakovaných infekcí a alergií po 10 a 20 letech. Alergie 2002; 4: 275-279.
    8. Bowman LM, Holt PG. Selective Enhancement of Systemic Th1 Immunity in Immunologically Immature Rats with an Orally Administered Bacterial Extract. Infection and Immunity, 2001: 3719-3727. Go to original source... Go to PubMed...
    9. Byl B, Libin M, Gerard M, et al. Bacterial extract OM85.BV induces interleukin -12 dependent IFN-gamma production by human CD4+ T cells. Journal of Interferon and Cytokine Research 1998; 18(10): 817-821. Go to original source... Go to PubMed...
    10. Spisek R, Brazova J, Rozkova D, et al. Maturation of dendritic cells by bacterial immunomodulators. Vaccine, 2004; 22(21-22): 2761-2768. Go to original source... Go to PubMed...
    11. Bystroň J, Heřmanová Z, Szotkovská J, Pazderová D. Investigation of clinical efficacy and influence of ribosomal immunotherapy on plasma levels of cytokines IL-4, IL-5, IL-12, IFN? and total IgE in grass-pollen allergy patients during pollen-season. Allergy, 57, 2002, suppl. 73, abstract No 173.
    12. Bystroň J, Heřmanová Z, Szotkovská J, Heller L. Comparison of ribosomal immunotherapy on plasmatic levels of. total IgE and cytokines IL-4,IL-5,IL-12 and IFN? in atopic and non-atopic adults during grass-pollen season. Allergy 2002; 57(Suppl. 73), abstract 176. Go to PubMed...
    13. Bene MC, Faure GC. From Peyer´s patches to tonsills. Specific stimulation with ribosomal immunotherapy. Drugs 1997; 54(Suppl. 1): 24-28. Go to original source... Go to PubMed...
    14. HbabiHaddioui L, Roques C. Inhibition of Streptococcus pneumoniae adhesion by specific salivary IgA after oral immunisation with a ribosomal. Drugs 1997; 54: 29-32. Go to original source... Go to PubMed...
    15. Lanzilli G, Falcheti R, et al. In vivo effect of an immunostimulating bacterial lysate on human B lymfocytes. Int J Immunopathol Pharmacol. 2006; 19: 551-559. Go to original source... Go to PubMed...
    16. Morandi B, Agazzi A, et al. A mixture of bacterial mechanical lysates is more efficient than single swain lysate and of bacterial-derived soluble proiductes for the induction of an activating phenotype in human dendritic cells. Immunol. Lett. 2011; 138(1): 86-91. Go to original source... Go to PubMed...
    17. Brado F, Tarantini F, Ghiglione V, et al. Bakteria lysate in the prevention of acute exacerbation respiratory recurrent infections. Int J Chron Obstruct Pulmon Dis 2007; 2(3): 335-345. Go to PubMed...
    18. Bystroň J. K otázce použití u nás dostupných perorálních imunomodulátorů v klinické praxi. Prakt. Lék. 1994; 74: 250-253.
    19. Jara-Pérez JV, Berber A. Primary Prevention of Acute Respiratrory Tract Infections in Children Using a Bacterial Immunostimulant: A Double-Masked, Placebo-Controlled Clinical Trial. Clinical Therapeutics 2000; 22(6): 748-759. Go to original source... Go to PubMed...
    20. Bystroň J. Bakteriální imunomodulátory v ORL praxi. Otorinolaryng. a Foniat. 2000; 2: 73-81.
    21. Del-Rio-Navarro BE, Luis Sierra-Monge JJ, Berber A, et al. Use of OM-85 BV in children suffering from recurrent respiratory tract infection and subnormal IgG subclass levels. Allergologia et Immunopathologia 2003; 31(1): 7-13. Go to original source... Go to PubMed...
    22. Grevers G, Palacios OA, Rodrigues B, et al. Treatment of recurrent respiratory tract infections with a polyvalent bacterial lysate: results of an open prospective, multinational study. Adv.Ther. 2000; 17(2): 103-116. Go to original source... Go to PubMed...
    23. Banche G, Allizond V, et al. Improvement of clinical response in allergic rhinitis patiens treated with an oral immunostimulating bacterial lysate: in vivo immunological effects. International J Immunopathol Pharmacol 2007; 20: 129-138. Go to original source... Go to PubMed...
    24. Hyrych KL, Inman RD. Infectious agents in chronic rheumatic diseases. Curr. Opin. Rheumatol. 2001; 13(4): 300-304. Go to original source... Go to PubMed...
    25. Rovenský J, Švík K, Stančíková M, Ištok R. Vplyv imunostimulačného preparátu Ribomunylu na účinok cyklosporínu a metotrexátu při adjuvantnej artritíde u potkanov. Rheumatologia 2003; 17(1): 15-27.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.